30% of Diabetes Patients Admit Skipping Insulin Injections




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics, adolescents and adults. In this exclusive interview, DeCock outlines the origins and